News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,411 Results
Type
Article (87554)
Company Profile (827)
Press Release (775011)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233106)
Career Advice (4140)
Deals (39813)
Drug Delivery (141)
Drug Development (91289)
Employer Resources (203)
FDA (18302)
Job Trends (17407)
News (397509)
Policy (39932)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1694)
Antibody-drug conjugate (ADC) (269)
Approvals (18344)
Artificial intelligence (519)
Autoimmune disease (107)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4205)
Cardiovascular disease (367)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (716)
Cervical cancer (33)
Clinical research (75875)
Collaboration (1460)
Company closure (4)
Compensation (970)
Complete response letters (63)
COVID-19 (2966)
CRISPR (85)
C-suite (632)
Cystic fibrosis (142)
Data (5017)
Decentralized trials (2)
Denatured (65)
Depression (115)
Diabetes (471)
Diagnostics (7114)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (248)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99464)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133623)
Executive appointments (1000)
FDA (20906)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1311)
Gene editing (181)
Generative AI (52)
Gene therapy (573)
GLP-1 (1045)
Government (5397)
Grass and pollen (8)
Guidances (374)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (70)
Immunology and inflammation (258)
Immuno-oncology (22)
Indications (60)
Infectious disease (3220)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17932)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (92)
Longevity (13)
Lung cancer (595)
Lymphoma (289)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (148)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22797)
Metabolic disorders (1210)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (64)
Neuroscience (2778)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (584)
Opinion (317)
Ovarian cancer (144)
Pain (173)
Pancreatic cancer (181)
Parkinson's disease (248)
Partnered (32)
Patents (434)
Patient recruitment (344)
Peanut (57)
People (66380)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23402)
Phase II (32925)
Phase III (24829)
Pipeline (3039)
Policy (306)
Postmarket research (3554)
Preclinical (10578)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (717)
Real estate (7423)
Recruiting (79)
Regulatory (28168)
Reports (65)
Research institute (2698)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1068)
Venture capital (69)
Weight loss (413)
Women's health (63)
Worklife (21)
Date
Today (252)
Last 7 days (1164)
Last 30 days (3537)
Last 365 days (33699)
2025 (28947)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51092)
Australia (8982)
California (10038)
Canada (2964)
China (959)
Colorado (420)
Connecticut (445)
Delaware (288)
Europe (117454)
Florida (1471)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (833)
India (56)
Indiana (493)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (23)
Maine (80)
Maryland (1335)
Massachusetts (7498)
Michigan (321)
Minnesota (594)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2772)
New Mexico (32)
New York (2692)
North Carolina (1459)
North Dakota (10)
Northern California (4637)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2066)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3833)
Tennessee (153)
Texas (1566)
United States (36787)
Utah (301)
Virginia (257)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
There are 863,411 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Pesky ‘Macro Factors’—aka RFK Jr.—Come for Vaccine Pharmas’ Wallets
Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all suffering revenue hits to their vaccine programs.
November 7, 2025
·
4 min read
·
Annalee Armstrong
IgA nephropathy
Vera Builds ‘Compelling Profile’ for Atacicept in IgAN, Eyes Q4 Filing
The Phase III results impressed Guggenheim Partners analysts both in terms of efficacy and safety. If approved, atacicept would become the first APRIL/BAFF inhibitor for IgAN to make it to the market.
November 7, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Patient Dies After Receiving Intellia’s CRISPR Gene Therapy Candidate
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred. Intellia is working with experts to create a risk management program for nex-z.
November 7, 2025
·
2 min read
·
Tristan Manalac
Approvals
J&J Wins Expansion for Top-Selling Cancer Drug in First for Smoldering Multiple Myeloma
Darzalex Faspro’s approval for smoldering multiple myeloma could allow for earlier intervention and reduce the risk of progression to active disease.
November 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance
November 7, 2025
·
29 min read
Press Releases
Biomunex to Present Preclinical Data of its MAIT Engager Platform in Immuno-Oncology at 2025 SITC Annual Meeting
November 7, 2025
·
5 min read
Press Releases
Sanuwave Announces Q3 FY2025 Financial Results
November 7, 2025
·
16 min read
Press Releases
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
November 7, 2025
·
10 min read
Press Releases
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update
November 7, 2025
·
22 min read
Press Releases
Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
November 7, 2025
·
3 min read
1 of 86,342
Next
